Related Experiment Video
Updated: May 5, 2026

04:48
Swin-PSAxialNet: An Efficient Multi-Organ Segmentation Technique
Published on: July 5, 2024
996
CMT-BUSNet: Adaptive Fusion-Based Triple-Branch Hybrid Architecture for Explainable Breast Ultrasound Tumor
Hüseyin Kutlu1,2, Cemil Çolak2
1Department of Biostatistics and Medical Informatics, Faculty of Medicine, Adıyaman University, Adıyaman 02040, Türkiye.
Diagnostics (Basel, Switzerland)
|May 4, 2026
Summary
CMT-BUSNet, a hybrid deep learning model, excels in breast ultrasound tumor segmentation, offering improved boundary accuracy and built-in explainability compared to benchmarks. Further validation is needed for clinical use.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Computational Biology
Background:
- Accurate breast ultrasound tumor segmentation is crucial for diagnosis.
- Existing methods may lack boundary precision and interpretability.
- Hybrid architectures offer potential for improved performance.
Purpose of the Study:
- To introduce CMT-BUSNet, a novel hybrid architecture for breast ultrasound tumor segmentation.
- To evaluate CMT-BUSNet's performance against established benchmarks.
- To assess the model's explainability and cross-dataset transferability.
Main Methods:
- Developed CMT-BUSNet, integrating Convolutional Neural Networks (CNN), Mamba, and Transformer branches.
- Employed a CNN-anchored hierarchical parallel encoder with an Adaptive Feature Fusion Module (AFFM).
- Utilized Dense Nested Decoder and Boundary-Aware Composite Loss for segmentation and boundary delineation.
Main Results:
- Achieved a Dice Similarity Coefficient (DSC) of 0.9037 on the BUS-BRA dataset, outperforming nnU-Net v2 in boundary metrics (B-IoU: 0.611 vs. 0.557; HD95: 10.07 vs. 13.54 pixels).
- Demonstrated superior zero-shot transfer performance on the BUSI dataset (DSC = 0.6709 vs. 0.5579).
- Quantitative explainability (XAI) validation confirmed attribution faithfulness and uncertainty-error correlation.
Conclusions:
- CMT-BUSNet offers competitive segmentation accuracy with superior boundary delineation and built-in interpretability.
- The model shows promising preliminary cross-dataset transferability.
- Multicenter validation is recommended prior to clinical deployment.

